
New findings presented by Finnish researchers at the University of Turku further supports the potential benefits of probiotics during the first months of life, particularly with regards to respiratory health.
The scientists claim a near 30 percent reduction in respiratory illness among infants whose diets were supplemented daily with the probiotic Bifidobacterium animalis, subspecies BB-12, as compared to those in their control group.
They also used the study as an opportunity to further test a new form of slow-delivery medical pacifier designed to administer more accurate dosages of medicine to very young children. The pacifiers have a small opening in their backplate for the storage of drugs. In the case of this study, tablets of the BB-12 probiotic.
Continue reading: “Study: Probiotics May Help Protect Infants From Respiratory Illness”
















